Previous studies have explored the dysregulation of NUPR1 in numerous malignant tumors, such as brain tumors, lung cancer, breast cancer, colorectal cancer, and prostate cancer.41, 42, 43. The gene discussed is NUPR1; the disease is prostate carcinoma.